ARTICLE | Company News
Aveo Pharmaceuticals, J&J deal
May 20, 2013 7:00 AM UTC
Aveo disclosed in a 10-Q filing that Johnson & Johnson's Janssen Biotech Inc. (formerly Centocor Ortho Biotech Inc.) unit terminated a 2011 deal to develop and commercialize mAbs for cancer on Dec. 6,...